Search Results - "Yamashita, Yo‐ichi"

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis by Sakamoto, Yuki, Mima, Kosuke, Ishimoto, Takatsugu, Ogata, Yoko, Imai, Katsunori, Miyamoto, Yuji, Akiyama, Takahiko, Daitoku, Nobuya, Hiyoshi, Yukiharu, Iwatsuki, Masaaki, Baba, Yoshifumi, Iwagami, Shiro, Yamashita, Yo‐ichi, Yoshida, Naoya, Komohara, Yoshihiro, Ogino, Shuji, Baba, Hideo

“…Fusobacterium nucleatum has been detected in 8%‐13% of human colorectal cancer, and shown to inhibit immune responses against primary colorectal tumors in…”
Get full text

Impairment of perioperative activities of daily living is associated with poor prognosis following hepatectomy for hepatocellular carcinoma by Mima, Kosuke, Imai, Katsunori, Kaida, Takayoshi, Matsumoto, Takashi, Nakagawa, Shigeki, Sawayama, Hiroshi, Hayashi, Hiromitsu, Yamashita, Yo‐ichi, Baba, Hideo

“…Background The number of cancer patients with impairment of activities of daily living (ADLs) has increased. This study aimed to examine associations of…”
Get full text

PD‐L1 expression enhancement by infiltrating macrophage‐derived tumor necrosis factor‐α leads to poor pancreatic cancer prognosis by Tsukamoto, Masayo, Imai, Katsunori, Ishimoto, Takatsugu, Komohara, Yoshihiro, Yamashita, Yo‐ichi, Nakagawa, Shigeki, Umezaki, Naoki, Yamao, Takanobu, Kitano, Yuki, Miyata, Tatsunori, Arima, Kota, Okabe, Hirohisa, Baba, Yoshifumi, Chikamoto, Akira, Ishiko, Takatoshi, Hirota, Masahiko, Baba, Hideo

“…Immunotherapy using anti‐PD‐1/PD‐L1 antibodies for several types of cancer has received considerable attention in recent decades. However, the molecular…”
Get full text

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma by Umezaki, Naoki, Nakagawa, Shigeki, Yamashita, Yo‐ichi, Kitano, Yuki, Arima, Kota, Miyata, Tatsunori, Hiyoshi, Yukiharu, Okabe, Hirohisa, Nitta, Hidetoshi, Hayashi, Hiromitsu, Imai, Katsunori, Chikamoto, Akira, Baba, Hideo

“…Hepatocellular carcinoma (HCC) has high recurrence rates even after curative hepatectomy. Drug therapy for recurrence of HCC is still limited; therefore,…”
Get full text

Prognostic significance of a novel index score based on the inflammation-based prognostic scores of patients with colorectal cancer by Kudou, Kensuke, Hasuda, Hirofumi, Tsuda, Yasuo, Kusumoto, Eiji, Uehara, Hideo, Yoshida, Rintaro, Koga, Tadashi, Yamashita, Yo-Ichi, Sakaguchi, Yoshihisa, Kusumoto, Tetsuya

“…This study aimed to clarify the prognostic value of various inflammation-based prognostic scores (IBPSs) in patients who underwent radical surgery for…”
Get full text

Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma by Yusa, Toshihiko, Yamashita, Yo‐ichi, Okabe, Hirohisa, Nakao, Yosuke, Itoyama, Rumi, Kitano, Yuki, Kaida, Takayoshi, Miyata, Tatsunori, Mima, Kosuke, Imai, Katsunori, Hayashi, Hiromitsu, Baba, Hideo

“…Inflammatory and immune cells in the tumor microenvironment are reported to be associated with tumor progression in several cancers. In total, 225 patients who…”
Get full text

Exploiting synergistic effect of externally loaded bFGF and endogenous growth factors for accelerated wound healing using heparin functionalized PCL/gelatin co-spun nanofibrous patches by Joshi, Akshat, Xu, Zhe, Ikegami, Yasuhiro, Yoshida, Kozue, Sakai, Yusuke, Joshi, Akshay, Kaur, Tejinder, Nakao, Yosuke, Yamashita, Yo-ichi, Baba, Hideo, Aishima, Shinichi, Singh, Neetu, Ijima, Hiroyuki

“…[Display omitted] •Heparin functionalized PCL/gelatin co-spun nanofibrous dressings were synthesized.•Fabricated dressings showed improved mechanical and…”
Get full text

Risk factors for bile leakage: Latest analysis of 10 102 hepatectomies for hepatocellular carcinoma from the Japanese national clinical database by Yamashita, Yo‐ichi, Yamamoto, Hiroyuki, Miyata, Hiroaki, Kakeji, Yoshihiro, Kitagawa, Yuko, Yamaue, Hiroki, Yamamoto, Masakazu, Baba, Hideo

“…Background/Purpose The aim of this study was to identify risk factors for bile leakage in hepatic resections without biliary reconstructions using the large…”
Get full text

The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study by Miyata, Tatsunori, Yamashita, Yo-ichi, Higashi, Takaaki, Taki, Katsunobu, Izumi, Daisuke, Kosumi, Keisuke, Tokunaga, Ryuma, Nakagawa, Shigeki, Okabe, Hirohisa, Imai, Katsunori, Hashimoto, Daisuke, Chikamoto, Akira, Baba, Hideo

“…Background Several studies have examined controlling nutritional status (CONUT), which is one of the useful biomarkers for predicting patients’ prognosis…”
Get full text

The microbiome and hepatobiliary-pancreatic cancers by Mima, Kosuke, Nakagawa, Shigeki, Sawayama, Hiroshi, Ishimoto, Takatsugu, Imai, Katsunori, Iwatsuki, Masaaki, Hashimoto, Daisuke, Baba, Yoshifumi, Yamashita, Yo-ichi, Yoshida, Naoya, Chikamoto, Akira, Baba, Hideo

“…Abstract The human intestinal microbiome encompasses at least 100 trillion microorganisms that can influence host immunity and disease conditions, including…”
Get full text

Clinicopathological characteristics of combined hepatocellular cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: High rate of early recurrence and its predictors by Yamashita, Yo‐ichi, Aishima, Shinichi, Nakao, Yosuke, Yoshizumi, Tomoharu, Nagano, Hiroaki, Kuroki, Tamotsu, Takami, Yuko, Ide, Takao, Ohta, Masayuki, Takatsuki, Mitsuhisa, Nanashima, Atsushi, Ishii, Fuminori, Kitahara, Kenji, Iino, Satoshi, Beppu, Toru, Baba, Hideo, Eguchi, Susumu

“…Aim Combined hepatocellular cholangiocarcinoma (cHCC‐CCA) is a very rare subtype of primary liver carcinoma; therefore, its clinicopathological characteristics…”
Get full text

Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer by Arima, Kota, Komohara, Yoshihiro, Bu, Luke, Tsukamoto, Masayo, Itoyama, Rumi, Miyake, Keisuke, Uchihara, Tomoyuki, Ogata, Yoko, Nakagawa, Shigeki, Okabe, Hirohisa, Imai, Katsunori, Hashimoto, Daisuke, Chikamoto, Akira, Yamashita, Yo‐ichi, Baba, Hideo, Ishimoto, Takatsugu

“…Chronic inflammation has a crucial role in cancer development and the progression of various tumors, including pancreatic ductal adenocarcinoma (PDAC). The…”
Get full text

Intraoperative bile culture helps choosing antibiotics in pancreaticoduodenectomy: Mechanistic profiling study of complex rink between bacterobilia and postoperative complications by Itoyama, Rumi, Okabe, Hirohisa, Yamashita, Yo‐ichi, Kitamura, Fumimasa, Uemura, Norio, Nakao, Yosuke, Yusa, Toshihiko, Imai, Katsunori, Hayashi, Hiromitsu, Baba, Hideo

“…Background Postoperative complications after pancreaticoduodenectomy (PD) is still a major concern. The aim of this study was to propose how to choose…”
Get full text

Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients by Kitano, Yuki, Yamashita, Yo-ichi, Nakao, Yosuke, Itoyama, Rumi, Yusa, Toshihiko, Umezaki, Naoki, Tsukamoto, Masayo, Yamao, Takanobu, Miyata, Tatsunori, Nakagawa, Shigeki, Okabe, Hirohisa, Imai, Katsunori, Chikamoto, Akira, Ishiko, Takatoshi, Baba, Hideo

“…Background The clinical significance of programmed death 1 and its ligand (PD-L1) as therapeutic targets has been reported previously. This study aimed to…”
Get full text

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis by Miyata, Tatsunori, Yamashita, Yo‐Ichi, Yoshizumi, Tomoharu, Shiraishi, Masayuki, Ohta, Masayuki, Eguchi, Susumu, Aishima, Shinichi, Fujioka, Hikaru, Baba, Hideo

“…Intrahepatic cholangiocarcinoma is a rare malignant biliary neoplasm that causes a poor prognosis even after curative hepatectomy. Liver metastasis is the…”
Get full text

Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma by Kitano, Yuki, Yamashita, Yo-ichi, Saito, Yoichi, Nakagawa, Shigeki, Okabe, Hirohisa, Imai, Katsunori, Komohara, Yoshihiro, Miyamoto, Yuji, Chikamoto, Akira, Ishiko, Takatoshi, Baba, Hideo

“…Background A decrease in skeletal muscle mass and function, defined as sarcopenia, is associated with poor postoperative outcome in patients with cancers…”
Get full text

The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma by Miyata, Tatsunori, Hayashi, Hiromitsu, Yamashita, Yo-ichi, Matsumura, Kazuki, Higashi, Takaaki, Imai, Katsunori, Nitta, Hidetoshi, Chikamoto, Akira, Beppu, Toru, Baba, Hideo

“…Background Liver inflammation is a reaction to disease-causing stress in the liver that induces fibrosis and cirrhosis. However, its prognostic impact after…”
Get full text

Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma by Lan, Chuan, Kitano, Yuki, Yamashita, Yo-ichi, Yamao, Takanobu, Kajiyama, Kiyoshi, Yoshizumi, Tomoharu, Fukuzawa, Kengo, Sugimachi, Keishi, Ikeda, Yasuharu, Takamori, Hiroshi, Miyanari, Nobutomo, Hirota, Masahiko, Baba, Hideo

“…Background Caveolin-1 (CAV1) in cancer-associated fibroblasts (CAFs) has pro- or anti-tumourigenic effect depending on the cancer type. However, its effect in…”
Get full text

Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species by Kitano, Yuki, Baba, Yoshifumi, Nakagawa, Shigeki, Miyake, Keisuke, Iwatsuki, Masaaki, Ishimoto, Takatsugu, Yamashita, Yo‐ichi, Yoshida, Naoya, Watanabe, Masayuki, Nakao, Mitsuyoshi, Baba, Hideo

“…Cancer cells consume a large amount of energy and maintain high levels of anabolism to promote cell proliferation via metabolic reprogramming. Nuclear factor…”
Get full text

Recent advances in precision medicine for pancreatic ductal adenocarcinoma by Hayashi, Hiromitsu, Higashi, Takaaki, Miyata, Tatsunori, Yamashita, Yo‐ichi, Baba, Hideo

“…Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Although advances in systemic chemotherapy for PDAC have…”
Get full text